WallStreetZenWallStreetZen

NASDAQ: ORGO
Organogenesis Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ORGO past earnings growth

How has ORGO's earnings growth performed historically?
Company
-66.67%
Industry
13.39%
Market
61.16%
ORGO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ORGO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ORGO past revenue growth

How has ORGO's revenue growth performed historically?
Company
-3.94%
Industry
10.23%
Market
16.96%
ORGO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ORGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ORGO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ORGO earnings and revenue history

Current Revenue
$433.1M
Current Earnings
$4.9M
Current Profit Margin
1.1%

ORGO Return on Equity

Current Company
1.8%
Current Industry
15.4%
Current Market
188%
ORGO's Return on Equity (1.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ORGO announces earnings.

ORGO Return on Assets

Current Company
1.1%
Current Industry
3.4%
ORGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ORGO Return on Capital Employed

Current Company
3.32%
Current Industry
5.1%
ORGO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORGO vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ORGO$433.14M$36.03M$4.95M+17.49%-90.86%
ESPR$116.33M-$150.11M-$209.25M-5.90%N/A
HROW$130.19M$9.95M-$24.41M+25.77%N/A
ACB$199.23M-$66.17M-$106.90M+17.87%N/A
PROC$414.10M$75.58M$52.20M-61.31%-38.62%
View Top Pharmaceutical Stocks

ORGO earnings dates

Next earnings date
May 8, 2024

Organogenesis Holdings Earnings & Revenue FAQ

What were ORGO's earnings last quarter?

On Invalid Date, Organogenesis Holdings (NASDAQ: ORGO) reported Q4 2023 earnings per share (EPS) of $0.00, up 100% year over year. Total Organogenesis Holdings earnings for the quarter were -$568.00 thousand. In the same quarter last year, Organogenesis Holdings's earnings per share (EPS) was $0.06.

If you're new to stock investing, here's how to buy Organogenesis Holdings stock.

What was ORGO's earnings growth in the past year?

As of Q2 2024, Organogenesis Holdings's earnings has grown -66.67% year over year. This is 80.05 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 13.39%. Organogenesis Holdings's earnings in the past year totalled $4.95 million.

What is ORGO's earnings date?

Organogenesis Holdings's earnings date is Invalid Date. Add ORGO to your watchlist to be reminded of ORGO's next earnings announcement.

What was ORGO's revenue last quarter?

On Invalid Date, Organogenesis Holdings (NASDAQ: ORGO) reported Q4 2023 revenue of $99.65 million up 13.73% year over year. In the same quarter last year, Organogenesis Holdings's revenue was $115.52 million.

What was ORGO's revenue growth in the past year?

As of Q2 2024, Organogenesis Holdings's revenue has grown -3.94% year over year. This is 14.16 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.23%. Organogenesis Holdings's revenue in the past year totalled $433.14 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.